Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 t...
Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol
About this item
Full title
Author / Creator
Cao, Lu , Zhang, Xue , Cao, Fanfan , Wang, Ying , Shen, Yufan , Yang, Chunxin , Uzan, Georges , Peng, Bin and Zhang, Denghai
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Celastrol is a novel anti-tumor agent. Ways to further enhance this effect of celastrol has attracted much research attention.
Here, we report that celastrol treatment can elevate miR-223 in human breast cancer cell line MCF-7 and prostate cancer PC3. Down-regulating miR-223 could increase the number of viable cells, yet it further reduced viabl...
Alternative Titles
Full title
Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4640397
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4640397
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-015-1909-2
